<div id="readability-page-1"><p>CanSino Biologics Inc. at its EGM held on November 27, 2025, approved appointment of Mr. Man CHO as an independent non-executive Director of the third session of the Board of Directors and appointment of Ms. Xuefeng JI as an independent non-executive Director of the third session of the Board of Directors. The Board of Directors announced that, at the Board of Directors meeting of the Company held immediately following the EGM, the Board of Directors resolved to adjust the<br/> composition of the committees under the Board of Directors with effect from November 27, 2025, until the expiry of the term of the third session of the Board of Directors. Audit Committee: Mr. Yiu Leung Andy CHEUNG (Chairman); Ms. Xuefeng JI; Mr. Chi Shing LI. Remuneration and Assessment Committee: Mr. Man CHO (Chairman); Mr. Yiu Leung Andy CHEUNG; Ms. Xuefeng JI; Mr. Chi Shing LI; Dr. Xuefeng YU. Nomination Committee: Ms. Xuefeng JI (Chairwoman); Mr. Man CHO; Dr. Xuefeng YU.</p></div>

康希诺

康希诺生物

<p>康希诺生物股份有限公司于 2025 年 11 月 27 日的股东特别大会上任命 Man Cho 和 Xuefeng Ji 为独立非执行董事，并调整了委员会的组成。变更包括审计、薪酬与考核以及提名委员会的新主席和成员，直至第三届董事会结束</p>

康希诺生物股份公司任命 Man Cho 和季学峰为独立非执行董事，并调整委员会的组成